Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-09 · accession 0001437749-21-026560 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-12 | 2021-11-09 | BLFS | Schulz Marcus | Chief Revenue Off | S - Sale | $53.00 | -1,750 | 29.1K | -6% | -$92.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-09 | S | D | 1,750 | $53.00 | 29,053 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of August 19, 2021. |